XTRA:RDCConsumer Retailing
How Investors May Respond To Redcare Pharmacy (XTRA:RDC) Reaffirming 2026 Revenue Growth Guidance After Q1 Update
Earlier in May 2026, Redcare Pharmacy NV reported first-quarter sales of €849.5 million, up from €717.3 million a year earlier, alongside a slightly reduced net loss of €10.5 million versus €10.8 million, and confirmed its 2026 earnings guidance for total revenue growth of 13% to 15%.
The combination of strong year-on-year sales expansion and reaffirmed full-year growth expectations gives investors clearer visibility into how Redcare’s scale-up is affecting both its top line and path toward...